Physician profile
Barbara Wells
NPI 1376520965
$1,309.19
in general payments reported to CMS, 2019-2025
21 companies · $304 in 2025
The $304 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $103 · 2020: $110 · 2021: $266 · 2022: $74.67 · 2023: $148 · 2024: $303 · 2025: $304.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $728 · Education: $26.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $728.45 |
| Education | $26.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $199.66 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Hologic Sales and Service, LLC | $143.10 | 2021-2025 | Aptima |
| Astellas Pharma US INC | $139.94 | 2023-2025 | Veozah |
| Ethicon US, LLC | $114.30 | 2024-2025 | Ethicon, Dermabond |
| Bayer Healthcare Pharmaceuticals INC. | $108.74 | 2019-2025 | |
| Sage Therapeutics, LLC | $77.09 | 2024-2025 | Zurzuvae |
| Therapeuticsmd, INC. | $66.91 | 2019-2021 | |
| Sumitomo Pharma America, INC. | $66.51 | 2023-2025 | Myfembree |
| Dysis Medical, INC. | $57.61 | 2021 | |
| Merck Sharp & Dohme LLC | $55.78 | 2019-2021 | |
| Mayne Pharma Commercial LLC | $39.70 | 2022-2025 | |
| Amag Pharmaceuticals, INC. | $37.13 | 2019-2020 | |
| Pfizer INC. | $36.50 | 2024 | |
| Mylan Pharmaceuticals INC. | $32.18 | 2021-2022 | |
| Millicent US INC | $26.70 | 2024 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $24.29 | 2025 | Qelbree |
| Medicem INC. | $19.10 | 2021 | |
| Novo Nordisk INC | $18.56 | 2025 | Wegovy |
| Organon LLC | $18.38 | 2022 | |
| Coopersurgical, INC. | $14.07 | 2021 | |
| Neos Therapeutics, LP | $12.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barbara Wells listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.